Publication | Closed Access

A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes

VaccinationVaccine DevelopmentNeutralizing AntibodiesVaccine TargetImmunologyAutoimmunityVaccine DesignHivImmunotherapyMedicineRecombinant LivePolyvalent Vaccine